Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |